Biosearch Technologies Signs Exclusive License for Single Molecule FISH Technologies from UMDNJ
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: 1 minute
Biosearch Technologies, Inc. (Biosearch), announces that the company has licensed exclusively from the University of Medicine and Dentistry of New Jersey (UMDNJ) a Single Molecule Fluorescent in-situ hybridization technology based on detection of RNA. Biosearch owns the exclusive rights to manufacture, catalogue and sell validated RNA FISH probes, assays and kits into the Research, Applied Markets and IVD fields under the UMDNJ technologies and patent applications.
Marc Beal, Director of Corporate Development at Biosearch Technologies, comments, “Biosearch’s excellence in fluorescence and fluorescent oligonucleotide manufacturing combined with the exclusive licensing of the UMDNJ RNA FISH technologies and patent applications will allow Biosearch to quickly penetrate the marketplace with both assays and kits. As the inventor and patent holder of the CAL Fluor® and Quasar® dye technologies, Biosearch will offer single and multiplexing application options for Research, Applied and IVD medical device markets as well as web-based design through www.singlemoleculefish.com.”
"We are very excited to work with Biosearch Technologies to commercialize this technology," says Arjun Raj, co-inventor of the single molecule FISH technology. "We have already seen widespread interest in applying this RNA FISH technique to directly quantify absolute numbers of RNA in a variety of contexts, and Biosearch has exactly the right expertise to put this technology in the hands of researchers and clinicians everywhere."
Vincent Smeraglia, Director of the Office of Patents & Licensing, UMDNJ stated, “We are pleased to have Biosearch Technologies as our licensing partner for this novel and exciting technology. We have no doubt that this partnership will result in innovative products that will serve the greater good of the research community and in the end, the public at large.”
Marc Beal, Director of Corporate Development at Biosearch Technologies, comments, “Biosearch’s excellence in fluorescence and fluorescent oligonucleotide manufacturing combined with the exclusive licensing of the UMDNJ RNA FISH technologies and patent applications will allow Biosearch to quickly penetrate the marketplace with both assays and kits. As the inventor and patent holder of the CAL Fluor® and Quasar® dye technologies, Biosearch will offer single and multiplexing application options for Research, Applied and IVD medical device markets as well as web-based design through www.singlemoleculefish.com.”
"We are very excited to work with Biosearch Technologies to commercialize this technology," says Arjun Raj, co-inventor of the single molecule FISH technology. "We have already seen widespread interest in applying this RNA FISH technique to directly quantify absolute numbers of RNA in a variety of contexts, and Biosearch has exactly the right expertise to put this technology in the hands of researchers and clinicians everywhere."
Vincent Smeraglia, Director of the Office of Patents & Licensing, UMDNJ stated, “We are pleased to have Biosearch Technologies as our licensing partner for this novel and exciting technology. We have no doubt that this partnership will result in innovative products that will serve the greater good of the research community and in the end, the public at large.”
